Skip to main content

Table 1 Demographical and clinical characteristics of group I, group II, and group III

From: Influenza A (H1N1) virus infection and TNF-308, IL6, and IL8 polymorphisms in Egyptian population: a case–control study

Parameters

Group I (n = 50)

Group II (n = 50)

Group III (n = 50)

p value

Age (years, mean ± SD)

44.14 ± 7.33

44.54 ± 7.33

37.22 ± 6.33

0.001*

Sex (male/female%)

(66%/34%)

(44%/56%)

(38%/62%)

0.013*

HCV

17 (34.0%)

7 (14.0%)

 

0.019*

Renal disease

9 (18.0%)

3 (6.0%)

 

0.065

Respiratory disease

20 (40.0%)

8 (16.0%)

 

0.265

CVD

10 (20.0%)

11 (22.0%)

 

0.806

Hypertension

9 (18.0%)

11 (22.0%)

 

0.617

Cancer

3 (6.0%)

1 (2.0%)

 

0.307

Diabetes

40 (80.0%)

15 (30.0%)

 

0.624

TB

13 (26.0%)

2 (4.0%)

 

0.976

Smoking history

11 (22.0%)

19 (38.0%)

 

0.081

PaO2

39 (78.0%)

27 (54.0%)

 

0.686

Mortality

7 (14.0%)

1 (2.0%)

 

0.027*

ICU

40 (80.0%)

29 (58.0%)

 

0.017*

Chest X-ray

 Infiltrate

7 (14%)

19 (38.0%)

 

0.012*

 Consolidation

30 (60%)

14 (28.0%)

 

0.003*

 Chest infection

8 (16%)

11 (22.0%)

 

0.601

 Others

5 (10%)

6 (12.0%)

 

0.976

 Fever

48 (96%)

30 (60%)

 

0.00*

 Cough

39 (78%)

19 (38.0%)

 

0.004*

 Sputum

50 (100.0%)

50 (100.0%)

 

1.000

 Sore throat

45 (90)

34 (68)

 

0.007*

 Headache

35 (70)

42 (84)

 

0.096

 Dyspnea

10 (20)

5 (10)

 

0.161

 Diarrhea

15 (30)

10 (18.5)

 

0.248

 Vomiting

10 (20)

2 (0.04)

 

0.0138

  1. SD standard deviation, CVD cardiac vascular disease, PaO2 partial pressure of oxygen, ICU intensive care unit, HCV hepatitis C virus
  2. *p values are significant